Inhibitors of β-Lactamases. New Life of β-Lactam Antibiotics
Authors:
- 26 November 2020
- journal article
- review article
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 85 (11) , 1292-1309
Abstract
β-Lactam antibiotics account for about 60% of all produced antibiotics. Due to a high activity and minimal side effects, they are the most commonly used class of antibacterial drugs for the treatment of various infectious diseases of humans and animals, including severe hospital infections. However, the emergence of bacteria resistant to β-lactams has led to the clinical inefficiency of these antibiotics, and as a result, their use in medicine has been limited. The search for new effective ways for overcoming the resistance to β-lactam antibiotics is an essential task. The major mechanism of bacterial resistance is the synthesis of β-lactamases (BLs) that break the antibiotic β-lactam ring. Here, we review specific inhibitors of serine β-lactamases and metallo-β-lactamases and discuss approaches for creating new inhibitors that would prolong the “life” of β-lactams.Keywords
This publication has 95 references indexed in Scilit:
- Crystal Structure of a Preacylation Complex of the β-Lactamase Inhibitor Sulbactam Bound to a Sulfenamide Bond-Containing Thiol-β-lactamaseJournal of the American Chemical Society, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Characterization of the Inhibitor-Resistant SHV β-Lactamase SHV-107 in a Clinical Klebsiella pneumoniae Strain Coproducing GES-7 EnzymeAntimicrobial Agents and Chemotherapy, 2012
- CTX-M Enzymes: Origin and DiffusionFrontiers in Microbiology, 2012
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2011
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2011
- A role for flexible loops in enzyme catalysisCurrent Opinion in Structural Biology, 2010
- Three Decades of β-Lactamase InhibitorsClinical Microbiology Reviews, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- SHV-16, a β-Lactamase with a Pentapeptide Duplication in the Omega LoopAntimicrobial Agents and Chemotherapy, 2001